Financial Summary (All financials)
| In millions, except per share items | Oct-31-16 | Oct-31-15 | Oct-31-14 | Oct-31-13 |
| Revenues | 1,867 | 1,774 | 1,484 | 991 |
| Revenue growth | 5.2% | 19.6% | 49.8% | |
| Cost of goods sold | 1,321 | 1,216 | 1,096 | 750 |
| Gross profit | 546 | 559 | 387 | 241 |
| Gross margin | 29.2% | 31.5% | 26.1% | 24.3% |
| Selling, general and administrative | 323 | 309 | 239 | 157 |
| Research and development | 2 | 15 | 14 | 10 |
| EBITA | 250 | 266 | 157 | 76 |
| EBITA margin | 13.4% | 15.0% | 10.6% | 7.7% |
| Amortization of intangibles | 25 | 23 | 12 | |
| EBIT | 226 | 243 | 145 | 76 |
| EBIT margin | 12.1% | 13.7% | 9.8% | 7.7% |
| Pre-tax income | 11 | 35 | -113 | -36 |
| Income taxes | -24 | 0 | 4 | -4 |
| Tax rate | | 0.9% | | 10.2% |
| Earnings from continuing ops | 35 | 35 | -117 | -33 |
| Earnings from discontinued ops | | | | -36 |
| Net income | 32 | 138 | -119 | -69 |
| Net margin | 1.7% | 7.8% | -8.0% | -6.9% |
| |
| Diluted EPS | $0.28 | $0.30 | ($1.01) | |
| Shares outstanding (diluted) | 124 | 116 | 116 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|